Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20003788
Conclusion of this study
Our study suggested that remifemin was one effective and safe agent to manage women with climacteric symptom. It has similar therapeutic effect and lower incidence of adverse effect when compared with tibolone.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
